Ophthalmology · Palm Springs, CA
NPI
1780872671
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1180 N Indian Canyon Dr Ste W100
Palm Springs, CA, 92262
Phone (760) 320-8497
Groups this clinician bills Medicare through
Medicare paid, 2024
$635K
36,958 services
Medicare patients, 2024
1,446
Average age 75
Drug cost, 2024
$2.6M
5,894 prescriptions
Company payments, 2025
$1,098
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wallace F Goldban was code J2403 (chloroprocaine hcl ophthalmic, 3% gel, 1 mg), 28,800 times for 13 patients. In total Wallace F Goldban billed 36,958 services in 53 codes, and Medicare paid $635K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 28,800 | 13 | $0.48 | $14K |
| 92012 Ophthalmological E&M | Office | 2,834 | 919 | $71.19 | $202K |
| 99214 Office E&M - Established | Office | 1,029 | 815 | $98.81 | $102K |
| 92134 Computerized Ophthalmic Imaging | Office | 589 | 468 | $31.83 | $19K |
| 68761 Eye | Office | 575 | 219 | $151.19 | $87K |
| 92250 Angiography | Office | 562 | 548 | $29.56 | $17K |
| 99442 Telephone Services | Office | 465 | 318 | $52.25 | $24K |
| 92133 Computerized Ophthalmic Imaging | Office | 318 | 305 | $26.70 | $8,491 |
| 92083 Vision, Hearing, and Speech Services | Office | 309 | 302 | $50.23 | $16K |
| 99204 Office E&M - New | Office | 292 | 292 | $121.26 | $35K |
| 92136 Ultrasound - Nonspecific | Office | 125 | 98 | $35.45 | $4,431 |
| 66984 Cataract Surgery | Facility | 116 | 85 | $439.11 | $51K |
| 83516 Immunoassay | Office | 88 | 44 | $11.30 | $994 |
| 92014 Ophthalmological E&M | Office | 56 | 52 | $101.49 | $5,684 |
| 67820 Eye | Office | 55 | 19 | $14.47 | $796 |
By year: 2022 $638K for 9,371 services; 2023 $438K for 8,788 services; 2024 $635K for 36,958 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83516 Immunoassay | 88 | 44 | $11.30 | $994 |
| 83861 Clinical Chemistry | 52 | 26 | $22.03 | $1,146 |
Medicare prescription drug claims, 2024
In 2024, the drug Wallace F Goldban prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 582 prescriptions and refills. In total Wallace F Goldban wrote 5,894 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 582 | 1,203 | 223 | $791K |
| Latanoprost Generic | 492 | 1,136 | 161 | $6,871 |
| Cyclosporine Generic | 436 | 1,094 | 213 | $329K |
| Prednisolone Acetate Generic | 398 | 430 | 212 | $12K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 370 | 379 | 249 | $3,849 |
| Azelastine Hcl Generic | 333 | 382 | 124 | $8,005 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 328 | 702 | 87 | $6,610 |
| Ketorolac Tromethamine Generic | 278 | 285 | 170 | $4,113 |
| Restasis Cyclosporine | 254 | 586 | 131 | $339K |
| Ofloxacin Generic | 248 | 252 | 174 | $2,583 |
| Vyzulta Latanoprostene Bunod | 195 | 357 | 53 | $102K |
| Cequa Cyclosporine | 191 | 393 | 81 | $228K |
| Lumigan Bimatoprost | 181 | 402 | 60 | $108K |
| Timolol Maleate Generic | 172 | 360 | 55 | $2,936 |
| Fluorometholone Generic | 122 | 140 | 84 | $7,471 |
Brand drugs: 3,445 claims; generic drugs: 2,449 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wallace F Goldban $1,098 ($1,098 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bausch & Lomb Americas Inc. with $300.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 23 | $300 |
| Alcon Vision LLC ALC | 10 | $222 |
| Abbvie Inc. ABBV | 8 | $170 |
| Amgen Inc. AMGN | 4 | $105 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $65.76 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $53.14 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $53.1 |
| Harrow Eye, LLC | 2 | $47.3 |
| Mallinckrodt Hospital Products Inc. | 1 | $33.61 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $24.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.